JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 1 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $169,305 | +69.0% | 91,516 | +1.4% | 0.00% | – |
| Q4 2022 | $100,187 | -99.8% | 90,259 | +354.1% | 0.00% | – |
| Q3 2022 | $46,510,000 | +68.4% | 19,876 | +118.1% | 0.00% | – |
| Q2 2022 | $27,618,000 | -9.5% | 9,115 | +102.9% | 0.00% | – |
| Q1 2022 | $30,501,000 | -72.5% | 4,492 | -66.2% | 0.00% | – |
| Q4 2021 | $110,863,000 | +58.6% | 13,277 | +41.2% | 0.00% | – |
| Q3 2021 | $69,887,000 | +211.2% | 9,406 | +184.8% | 0.00% | – |
| Q2 2021 | $22,460,000 | -72.1% | 3,303 | -57.8% | 0.00% | – |
| Q1 2021 | $80,383,000 | +267.0% | 7,827 | +150.1% | 0.00% | – |
| Q4 2020 | $21,903,000 | -28.2% | 3,129 | -16.3% | 0.00% | – |
| Q3 2020 | $30,494,000 | +405.6% | 3,737 | +327.6% | 0.00% | – |
| Q2 2020 | $6,031,000 | -74.9% | 874 | -82.7% | 0.00% | – |
| Q1 2020 | $24,040,000 | -29.4% | 5,061 | +29.8% | 0.00% | – |
| Q4 2019 | $34,047,000 | +294.9% | 3,900 | +50.6% | 0.00% | – |
| Q3 2019 | $8,621,000 | -32.9% | 2,589 | -0.2% | 0.00% | – |
| Q2 2019 | $12,840,000 | -38.0% | 2,594 | -22.3% | 0.00% | – |
| Q1 2019 | $20,696,000 | +1443.3% | 3,338 | +738.7% | 0.00% | – |
| Q4 2018 | $1,341,000 | -67.5% | 398 | -37.3% | 0.00% | – |
| Q3 2018 | $4,128,000 | -47.6% | 635 | -38.3% | 0.00% | – |
| Q2 2018 | $7,882,000 | -88.8% | 1,029 | -67.2% | 0.00% | – |
| Q1 2018 | $70,112,000 | +99.2% | 3,137 | +13.7% | 0.00% | – |
| Q4 2017 | $35,190,000 | +259.1% | 2,760 | +338.8% | 0.00% | – |
| Q3 2017 | $9,800,000 | +4.9% | 629 | -5.6% | 0.00% | – |
| Q2 2017 | $9,344,000 | – | 666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $9,152,000 | 93.42% |
| Ally Bridge Group (NY) LLC | 550,000 | $3,735,000 | 2.77% |
| ACUTA CAPITAL PARTNERS, LLC | 813,500 | $5,524,000 | 2.58% |
| TRV GP III, LLC | 1,148,780 | $7,800,000 | 2.12% |
| Deep Track Capital, LP | 4,259,653 | $28,923,000 | 1.86% |
| Logos Global Management LP | 1,400,000 | $9,506,000 | 1.23% |
| PFM Health Sciences, LP | 3,972,868 | $26,976,000 | 1.01% |
| Sofinnova Investments, Inc. | 1,481,219 | $10,057,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 248,347 | $1,686,000 | 0.70% |
| RTW INVESTMENTS, LP | 4,680,412 | $31,780,000 | 0.66% |